Tabuk Pharmaceuticals employs over 3,500 people. It has four manufacturing sites in Tabuk and Dammam in Saudi Arabia, Algeria, and Sudan, producing two billion base units annually, of which the Tabuk plant—its largest plant—produces 1.6 billion units. The company provides products for 17 countries across MENA. Tabuk was nominated as the sole private sector representative for the pharma industry at Saudi-FDA Board of Directors. Al Hagbani has also been the group president of the Astra Industries Group since 2014, and is the chairman of Aljazira Capital.